TY - JOUR
T1 - Identification of a new collagen IV chain, α6(IV), by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5
AU - Oohashi, Toshitaka
AU - Sugimoto, Manabu
AU - Mattei, Marie Genevieve
AU - Ninomiya, Yoshifumi
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1994/3/11
Y1 - 1994/3/11
N2 - To date, five distinct α chains have been identified in basement membrane collagen IV. We have cloned a gene encoding a new α chain belonging to basement membrane collagen IV by cDNA isolation under low stringency conditions. Isolation of overlapping clones and the technique of 5' rapid amplification of cDNA ends enabled us to derive the primary structure of the entire polypeptide. The deduced collagen polypeptide contained 1678 amino acid residues, including a 21-residue signal peptide, a 24-residue amino- terminal NC domain, a central 1405-residue collagenous (COL1) domain, and a 228-residue carboxyl-terminal NC1 domain. We have designated this newly found α chain as the α6(IV) chain. The gene was mapped to chromosome Xq22 by in situ hybridization of metaphase lymphocytes. This is the same region of chromosome X where the gene coding for the α5(IV) collagen chain (COL4A5) resides. Mutations in COL4A5 have been characterized in more than 50 patients with Alport syndrome. However, some of the X-linked cases of Alport syndrome are not apparently caused by COL4A5 mutations. The gene we describe in this paper therefore seems to be a candidate for mutations in this group of Alport syndrome patients.
AB - To date, five distinct α chains have been identified in basement membrane collagen IV. We have cloned a gene encoding a new α chain belonging to basement membrane collagen IV by cDNA isolation under low stringency conditions. Isolation of overlapping clones and the technique of 5' rapid amplification of cDNA ends enabled us to derive the primary structure of the entire polypeptide. The deduced collagen polypeptide contained 1678 amino acid residues, including a 21-residue signal peptide, a 24-residue amino- terminal NC domain, a central 1405-residue collagenous (COL1) domain, and a 228-residue carboxyl-terminal NC1 domain. We have designated this newly found α chain as the α6(IV) chain. The gene was mapped to chromosome Xq22 by in situ hybridization of metaphase lymphocytes. This is the same region of chromosome X where the gene coding for the α5(IV) collagen chain (COL4A5) resides. Mutations in COL4A5 have been characterized in more than 50 patients with Alport syndrome. However, some of the X-linked cases of Alport syndrome are not apparently caused by COL4A5 mutations. The gene we describe in this paper therefore seems to be a candidate for mutations in this group of Alport syndrome patients.
UR - http://www.scopus.com/inward/record.url?scp=0028229871&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028229871&partnerID=8YFLogxK
M3 - Article
C2 - 8125972
AN - SCOPUS:0028229871
SN - 0021-9258
VL - 269
SP - 7520
EP - 7526
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 10
ER -